NCT07466927 2026-03-12
Study of Multi-mode Thermal Therapy Combined With Immunotherapy In Patients With HER2-negative Breast Cancer With Liver Metastases
Fudan University
Phase 2 Not yet recruiting
Clinical Trials
5 trialsNCT06102824 2024-11-25
ORIENTA
Guangdong Provincial People's Hospital
Phase 2 Recruiting
NCT03575065 2024-10-26
Efficacy and Safety of BGB-290 in the Treatment of Metastatic HER2-Negative Breast Cancer Patients With BRCA Mutation in China
BeiGene
Phase 2 Completed
NCT04848454 2022-10-18
Efficacy and Safety of Combinition of Camrelizumab in Second-line Neoadjuvant Chemotherapy and Adjuvant Therapy
Peking University First Hospital
Phase 2 Unknown
NCT05263882 2022-03-03
Gemcitabine Combined With Eribulin Regimen in the Treatment of Second-line Above Recurrent HER2-negative Breast Cancer
Fifth Affiliated Hospital, Sun Yat-Sen University
Phase 2 Unknown